167 related articles for article (PubMed ID: 35749545)
1. HBV seroprevalence and liver fibrosis status among population born before national immunization in Southern Thailand: Findings from a health check-up program.
Sono S; Sae-Chan J; Kaewdech A; Chamroonkul N; Sripongpun P
PLoS One; 2022; 17(6):e0270458. PubMed ID: 35749545
[TBL] [Abstract][Full Text] [Related]
2. Chronic hepatitis B virus infection in Asian countries.
Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence and factors associated with hepatitis B virus infection among the hill tribe youths, northern Thailand.
Apidechkul T
BMC Infect Dis; 2019 Feb; 19(1):125. PubMed ID: 30727952
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program.
Peto TJ; Mendy ME; Lowe Y; Webb EL; Whittle HC; Hall AJ
BMC Infect Dis; 2014 Jan; 14():7. PubMed ID: 24397793
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence and factors associated with hepatitis B infection among the hill tribe adult population in Thailand: a cross-sectional study.
Upala P; Apidechkul T; Tamornpark R; Chomchoei C; Yeemard F
BMC Infect Dis; 2020 Jul; 20(1):494. PubMed ID: 32650741
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of hepatitis B virus among adults at high risk for HIV transmission two decades after implementation of nationwide hepatitis B virus vaccination program in Taiwan.
Sun HY; Cheng CY; Lee NY; Yang CJ; Liang SH; Tsai MS; Ko WC; Liu WC; Wu PY; Wu CH; Lin HH; Hung CC
PLoS One; 2014; 9(2):e90194. PubMed ID: 24587275
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and outcomes of HBV and anti-HCV seropositive patients with chronic liver disease and hepatocellular carcinoma.
Pramoolsinsap C; Sumalnop K; Busagorn N; Kurathong S
Southeast Asian J Trop Med Public Health; 1992 Mar; 23(1):6-11. PubMed ID: 1326124
[TBL] [Abstract][Full Text] [Related]
9. Survey of hepatitis B virus infection for liver cancer screening in China: A population-based, cross-sectional study.
Xu Y; Xia C; Li H; Cao M; Yang F; Li Q; Cao M; Chen W
Chin Med J (Engl); 2024 Jun; 137(12):1414-1420. PubMed ID: 38766992
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiological study of hepatitis B virus markers in Japan.
Kiyohara T; Ishii K; Mizokami M; Sugiyama M; Wakita T
Vaccine; 2015 Nov; 33(45):6037-42. PubMed ID: 26341564
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C-related hepatocellular carcinoma. Prevalence and significance.
Resnick RH; Koff R
Arch Intern Med; 1993 Jul; 153(14):1672-7. PubMed ID: 7687423
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection in chronic liver disease in Natal.
Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE
S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia.
Dondog B; Lise M; Dondov O; Baldandorj B; Franceschi S
Eur J Cancer Prev; 2011 Jan; 20(1):33-9. PubMed ID: 21166097
[TBL] [Abstract][Full Text] [Related]
14. The current and future burden of hepatitis B in Switzerland: a modelling study.
Negro F; Müllhaupt B; Semela D; Blach S; Bruggmann P; De Gottardi A; Dufour JF; Fraga M; Galante A; Razavi H; Vieira Barbosa J; Razavi-Shearer D
Swiss Med Wkly; 2023 Jun; 153():40086. PubMed ID: 37410921
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of hepatitis B virus surface antigen (HBsAg) in Egypt (2000-2022): a systematic review with meta-analysis.
Azzam A; Khaled H; Elbohy OA; Mohamed SA; Mohamed SMH; Abdelkader AH; Ezzat AA; Elmowafy AOI; El-Emam OA; Awadalla M; Refaey N; Rizk SMA
BMC Infect Dis; 2023 Mar; 23(1):151. PubMed ID: 36899311
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis E Virus Superinfection and Clinical Progression in Hepatitis B Patients.
Hoan NX; Tong HV; Hecht N; Sy BT; Marcinek P; Meyer CG; Song le H; Toan NL; Kurreck J; Kremsner PG; Bock CT; Velavan TP
EBioMedicine; 2015 Dec; 2(12):2080-6. PubMed ID: 26844288
[TBL] [Abstract][Full Text] [Related]
17. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of sero-markers and non-invasive assessment of liver cirrhosis in patients with Hepatitis B virus infection in Freetown, Sierra Leone: a cross-sectional study.
Lakoh S; Firima E; Jiba DF; Kamara MN; Gashau W; Deen GF; Adekanmbi O; Yendewa GA
BMC Gastroenterol; 2021 Aug; 21(1):320. PubMed ID: 34372775
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon.
Braga WS; Castilho Mda C; Borges FG; Martinho AC; Rodrigues IS; Azevedo EP; Scazufca M; Menezes PR
Rev Soc Bras Med Trop; 2012 Feb; 45(1):13-7. PubMed ID: 22370822
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B problem in Thailand.
Pramoolsinsap C; Pukrittayakamee S; Desakorn V
Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):219-28. PubMed ID: 3024326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
